摘要
针对引起广泛关注的中药中外源性有害物质残留问题,笔者综述近年来科研及药品标准建设的成果,对样品普查结果进行归纳总结,分析危害的性质,提出对中药中外源性有害物质的控制应纳入风险管理的科学框架之中,遵循风险控制的科学原理,创新监管手段,保证中药质量安全,促进行业发展。
More and more people have realized the problems of exogenous harmful residues in traditional Chinese medicines( TCMs). In this review,the current development in studies on and construction of drug standard was reviewed. Moreover,the sample census result and degree of harm were analyzed. It is proposed that the concept of risk management should be integrated into the control of exogenous harmful residues in TCMs. And we should follow the scientific principles of risk control and develop new supervision system to ensure the quality and safety of TCMs as well as the development of the industry.
出处
《中国药学杂志》
CAS
CSCD
北大核心
2015年第2期99-103,共5页
Chinese Pharmaceutical Journal
基金
"重大新药创制"国家科技重大专项课题"中药质量安全检测和风险控制技术平台"(2014ZX09304307-002)
关键词
中药
外源性有害残留
风险控制
法定标准
traditional Chinese medicine
exogenous harmful residue
risk control
statutory standard
